πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Nektar Therapeutics UK Patents

Full USPTO pharma patent portfolio for Nektar Therapeutics UK β€” grant dates, expiration, and drug cross-links.

Patents
423
Expiring ≀24m
24

Quick answer

Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β€” use filters for patent-cliff planning.

Page 1 of 9

  1. US 12324828

    Conjugates of a factor VIII moiety having an oxime-containing linkage

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12325708

    Adenosine 2 receptor antagonists

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12247059

    Conjugates of an IL-2 moiety and a polymer

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12233104

    Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12214045

    Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12054553

    Immunotherapeutic tumor treatment method

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12036283

    Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12030940

    Immunotherapeutic tumor treatment method

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12016952

    Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11932726

    Method of making releasable polymeric reagents

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11834553

    Alkoxylation methods

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11813241

    Multi-arm polymeric prodrug conjugates of taxane-based compounds

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11744898

    Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11672776

    Multi-arm polymeric alkanoate conjugates

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11634540

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11628205

    Conjugates of a factor VIII moiety having an oxime-containing linkage

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11612662

    Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11464788

    Oligomer-corticosteroid conjugates

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11446385

    Polymer derivatives having particular atom arrangements

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11419943

    Polymer-sunitinib conjugates

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11406618

    Polymer-des-ethyl sunitinib conjugates

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11318164

    Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapy

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11266742

    Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11241415

    N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the ΞΊ opioid receptor

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11220575

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11141465

    Method of making a water-soluble polymer-factor VIII moiety conjugate

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11129794

    Chemically modified small molecules

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11111214

    Kappa opioid agonists and uses thereof

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11111335

    Method of preparing carboxylic acid functionalized polymers

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11091525

    Method of refolding an interleukin-2 (IL-2) protein

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11033631

    Methods of treating CYP2D6 alternative metabolizers

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11007270

    Polymer-semaxanib moiety conjugates

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10960079

    Conjugates of an IL-2 moiety and a polymer

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10945972

    Particulate materials

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10941248

    Methods for preparing functionalized polymers from polymer alcohols

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10894087

    Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10881738

    Oligomer-beta blocker conjugates

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10869933

    Oligomer-phenothiazine conjugates

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10865186

    Opioid agonists and uses thereof

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10844076

    Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10806794

    Protease inhibitors having enhanced features

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10798955

    Compositions of particulate coformulation

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10786552

    Il-2RΞ²-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10774181

    N-maleimidyl polymer derivatives

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10766864

    Morphinan derivatives for the treatment of neuropathic pain

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10759906

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10736969

    Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10695435

    Composition comprising a polymeric reagent

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Nektar Therapeutics UK have?

423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Nektar Therapeutics UK patents expire?

24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.